Skin Inc

Trends Sponsored by

Email This Item!
Increase Text Size

Professional Skin Care Fatigued, Poised for Bright Future

Posted: June 24, 2010

After several years of strong growth, the global market for professional skin care products showed signs of fatigue in 2009. While Europe and the United States posted substantial declines, the exception to this trend came from the BRIC markets, spearheaded by Brazil, which posted growth of 11.1%, according to recently released study Professional Skin Care 2009 Global Series: Market Analysis and Opportunities from worldwide consulting and research firm Kline & Company.

“The recession's impact in Europe and the United States resulted in a change in spending patterns, a decline in the frequency of visits to spas and physician’s offices, and a shift to lower-priced brands,” notes Karen Doskow, industry manager at Kline. “But even in the face of a gloomy economy, industry leaders fought back with a healthy flow of new product launches, many of which targeted the anti-aging segment.”

She further explains, “Products that were unique, multitasking or offering dual benefits certainly stood out for the recession-stricken consumer. Professional skin care marketers acknowledged the need to diversify, segment and innovate their offerings in order to cater to a change in demand for the products that are preventive or that are proven to help reverse signs of aging.”

With the latest scientific findings and trailblazing innovations in ingredient research, professional skin care products, to some extent, compare to the results of cosmetic treatments. As consumers extend the time between in-office procedures, new products completing or replacing cosmetic procedures will grow in importance.

According to report findings, anti-aging products account for 41.1% in the United States, and nearly 50% of sales in Europe and Brazil. Responding to consumer needs, the product trends vary on a worldwide basis; skin whitening is a No. 1 concern for marketers in China and Japan, and anti-cellulite treatments are a top priority in Europe or Brazil.